{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T02:07:38Z","timestamp":1766455658001,"version":"3.48.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Key Project of Natural Science Research of the Anhui Provincial Department of Education","award":["No. 2022AH050701"],"award-info":[{"award-number":["No. 2022AH050701"]}]},{"name":"Chengguan District Science and Technology Bureau Project","award":["2020-2-11-9"],"award-info":[{"award-number":["2020-2-11-9"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The P53-mutated Hepatocellular Carcinoma (HCC) is an aggressive variant associated with vascular endothelial growth factor (VEGF) overexpression and increased microvascular density. This study aimed to develop an MRI-based deep learning model for predicting P53-mutated HCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 312 HCC patients who underwent gadolinium-enhanced MRI and were pathologically confirmed between January 2018 and December 2023 were retrospectively enrolled. Participants were randomly divided into training and test dataset at an 8:2 ratio. We developed an EfficientNetV2-based deep learning model, constructing arterial phase (AP) model, portal venous phase (VP), T2-weighted imaging (T2WI), hepatobiliary phase (HBP) single-sequence model, and combined models to predict P53 mutation status. Model performance was evaluated using the area under the curve (AUC), accuracy, sensitivity, specificity, precision, and F1 score as metrics. Differences in AUC values were compared using Delong\u2019s test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 312 pathologically confirmed HCC patients (age: 56\u2009\u00b1\u20099 years; male\u2009=\u2009240) were included, with a training dataset (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009249) and test dataset (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200963).Among single-sequence models, the HBP model demonstrated superior diagnostic performance (AUC\u2009=\u20090.715) compared to T2WI, AP, and VP models. The multiphase combined model (T2WI\u2009+\u2009AP\u2009+\u2009VP) significantly outperformed single-sequence models, achieving AUCs of 0.982 (95% CI: 0.959\u20131.000) in the training dataset and 0.914 (95% CI: 0.819\u20131.000) in the test dataset. However, incorporating the HBP sequence into the combined model (T2WI\u2009+\u2009AP\u2009+\u2009VP\u2009+\u2009HBP) did not further improve diagnostic performance (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Advances in knowledge<\/jats:title>\n                    <jats:p>The combined model incorporating AP, VP, T2WI, and HBP sequences demonstrated numerically highest performance in predicting P53-mutated HCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12880-025-02045-w","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T14:12:55Z","timestamp":1766412775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deep learning-based MRI model for predicting P53-mutated hepatocellular carcinoma"],"prefix":"10.1186","volume":"25","author":[{"given":"Lulu","family":"Jia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanchen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinkui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junqiang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"issue":"1","key":"2045_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Reviews Disease Primers. 2021;7(1):6.","journal-title":"Nat Reviews Disease Primers"},{"issue":"7","key":"2045_CR2","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","volume":"169","author":"The Cancer Genome Atlas Research Network","year":"2017","unstructured":"The Cancer Genome Atlas Research Network. Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell. 2017;169(7):1327\u2013e4123.","journal-title":"Cell"},{"issue":"6","key":"2045_CR3","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.ccell.2024.04.009","volume":"42","author":"Y Liu","year":"2024","unstructured":"Liu Y, Su Z, Tavana O, Gu W. Understanding the complexity of p53 in a new era of tumor suppression. Cancer Cell. 2024;42(6):946\u201367.","journal-title":"Cancer Cell"},{"issue":"3","key":"2045_CR4","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41568-023-00658-3","volume":"24","author":"S Peuget","year":"2024","unstructured":"Peuget S, Zhou X, Selivanova G. Translating p53-based therapies for cancer into the clinic. Nat Rev Cancer. 2024;24(3):192\u2013215.","journal-title":"Nat Rev Cancer"},{"issue":"21","key":"2045_CR5","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1056\/NEJMoa1605949","volume":"375","author":"JS Welch","year":"2016","unstructured":"Welch JS, Petti AA, Miller CA, Fronick CC, O\u2019Laughlin M, Fulton RS, et al. TP53 and decitabine in acute myeloid leukemia and myelodysplastic syndromes. N Engl J Med. 2016;375(21):2023\u201336.","journal-title":"N Engl J Med"},{"issue":"1","key":"2045_CR6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/ijc.32507","volume":"146","author":"F Sclafani","year":"2020","unstructured":"Sclafani F, Wilson SH, Cunningham D, Gonzalez De Castro D, Kalaitzaki E, Begum R, et al. Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients. Int J Cancer. 2020;146(1):94\u2013102.","journal-title":"Int J Cancer"},{"key":"2045_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ygyno.2025.01.006","volume":"193","author":"A Clements","year":"2025","unstructured":"Clements A, Enserro D, Strickland KC, Previs R, Matei D, Mutch D, et al. Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: ancillary analysis of GOG-0258. Gynecol Oncol. 2025;193:119\u201329.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"2045_CR8","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/liv.12460","volume":"35","author":"LN Qi","year":"2015","unstructured":"Qi LN, Bai T, Chen ZS, Wu FX, Chen YY, De Xiang B, et al. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, china: role of chronic hepatitis B virus infection and aflatoxin B1 exposure. Liver Int. 2015;35(3):999\u20131009.","journal-title":"Liver Int"},{"issue":"2","key":"2045_CR9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76(2):182\u20138.","journal-title":"Histopathology"},{"issue":"1","key":"2045_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/hep.29762","volume":"68","author":"M Ziol","year":"2018","unstructured":"Ziol M, Pot\u00e9 N, Amaddeo G, Laurent A, Nault JC, Oberti F, et al. Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance. Hepatology. 2018;68(1):103\u201312.","journal-title":"Hepatology"},{"issue":"1","key":"2045_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41392-021-00635-y","volume":"6","author":"C Yang","year":"2021","unstructured":"Yang C, Lou G, Jin WL. The arsenal of TP53 mutants therapies: neoantigens and bispecific antibodies. Signal Transduct Target Therapy. 2021;6(1):219.","journal-title":"Signal Transduct Target Therapy"},{"issue":"2","key":"2045_CR12","doi-asserted-by":"publisher","first-page":"108982","DOI":"10.1016\/j.celrep.2021.108982","volume":"35","author":"H Ramos","year":"2021","unstructured":"Ramos H, Soares MIL, Silva J, Raimundo L, Calheiros J, Gomes C, et al. A selective p53 activator and anticancer agent to improve colorectal cancer therapy. Cell Rep. 2021;35(2):108982.","journal-title":"Cell Rep"},{"issue":"2","key":"2045_CR13","doi-asserted-by":"publisher","first-page":"e220531","DOI":"10.1148\/radiol.220531","volume":"306","author":"A Kitao","year":"2023","unstructured":"Kitao A, Matsui O, Zhang Y, Ogi T, Nakada S, Sato Y, et al. Dynamic CT and Gadoxetic Acid-enhanced MRI characteristics of P53-mutated hepatocellular carcinoma. Radiology. 2023;306(2):e220531.","journal-title":"Radiology"},{"key":"2045_CR14","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.2147\/JHC.S462979","volume":"11","author":"J Weng","year":"2024","unstructured":"Weng J, Xiao Y, Liu J, Liu X, He Y, Wu F, et al. Exploring the MRI and clinical features of P53-Mutated hepatocellular carcinoma. J Hepatocellular Carcinoma. 2024;11:1653\u201374.","journal-title":"J Hepatocellular Carcinoma"},{"issue":"1","key":"2045_CR15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1055\/s-0039-1688758","volume":"58","author":"H Wu","year":"2019","unstructured":"Wu H, Chen X, Chen J, Luo Y, Jiang X, Wei X, et al. Correlations between P53 mutation status and texture features of CT images for hepatocellular carcinoma. Methods Inf Med. 2019;58(1):42\u20139.","journal-title":"Methods Inf Med"},{"issue":"10","key":"2045_CR16","doi-asserted-by":"publisher","first-page":"7185","DOI":"10.1007\/s00330-022-08927-9","volume":"32","author":"B Liu","year":"2022","unstructured":"Liu B, Zeng Q, Huang J, Zhang J, Zheng Z, Liao Y, et al. IVIM using convolutional neural networks predicts microvascular invasion in HCC. Eur Radiol. 2022;32(10):7185\u201395.","journal-title":"Eur Radiol"},{"issue":"12","key":"2045_CR17","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.3390\/cancers14122956","volume":"14","author":"L Wang","year":"2022","unstructured":"Wang L, Wu M, Li R, Xu X, Zhu C, Feng X. MVI-Mind: A novel Deep-Learning strategy using computed tomography (CT)-Based radiomics for End-to-End high efficiency prediction of microvascular invasion in hepatocellular carcinoma. Cancers. 2022;14(12):2956.","journal-title":"Cancers"},{"issue":"1","key":"2045_CR18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1186\/s12885-025-13781-1","volume":"25","author":"S Song","year":"2025","unstructured":"Song S, Zhang G, Yao Z, Chen R, Liu K, Zhang T, et al. Deep learning based on intratumoral heterogeneity predicts histopathologic grade of hepatocellular carcinoma. BMC Cancer. 2025;25(1):497.","journal-title":"BMC Cancer"},{"key":"2045_CR19","unstructured":"Tan M, Le Q. Efficientnetv2: Smaller models and faster training. In: Proceedings of the 38th International Conference on Machine Learning (ICML 2021). PMLR; 2021:10096\u2013106."},{"issue":"6","key":"2045_CR20","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.jhep.2019.02.023","volume":"70","author":"X Xu","year":"2019","unstructured":"Xu X, Zhang HL, Liu QP, Sun SW, Zhang J, Zhu FP, et al. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J Hepatol. 2019;70(6):1133\u201344.","journal-title":"J Hepatol"},{"issue":"1","key":"2045_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jhep.2020.08.013","volume":"74","author":"H Rhee","year":"2021","unstructured":"Rhee H, Cho ES, Nahm JH, Jang M, Chung YE, Baek SE, et al. Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications. J Hepatol. 2021;74(1):109\u201321.","journal-title":"J Hepatol"},{"issue":"1","key":"2045_CR22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1148\/radiol.2021203614","volume":"300","author":"Z Feng","year":"2021","unstructured":"Feng Z, Li H, Zhao H, Jiang Y, Liu Q, Chen Q, et al. Preoperative CT for characterization of aggressive Macrotrabecular-Massive subtype and vessels that encapsulate tumor clusters pattern in hepatocellular carcinoma. Radiology. 2021;300(1):219\u201329.","journal-title":"Radiology"},{"issue":"2","key":"2045_CR23","doi-asserted-by":"publisher","first-page":"e230255","DOI":"10.1148\/radiol.230255","volume":"308","author":"M Li","year":"2023","unstructured":"Li M, Fan Y, You H, Li C, Luo M, Zhou J, et al. Dual-Energy CT deep learning radiomics to predict Macrotrabecular-Massive hepatocellular carcinoma. Radiology. 2023;308(2):e230255.","journal-title":"Radiology"},{"issue":"3","key":"2045_CR24","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1148\/radiol.2020192230","volume":"295","author":"S Mul\u00e9","year":"2020","unstructured":"Mul\u00e9 S, Galletto Pregliasco A, Tenenhaus A, Kharrat R, Amaddeo G, Baranes L, et al. Multiphase liver MRI for identifying the Macrotrabecular-Massive subtype of hepatocellular carcinoma. Radiology. 2020;295(3):562\u201371.","journal-title":"Radiology"},{"issue":"6","key":"2045_CR25","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.jhep.2013.07.030","volume":"59","author":"M Ziol","year":"2013","unstructured":"Ziol M, Sutton A, Calderaro J, Barget N, Aout M, Leroy V, et al. ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma. J Hepatol. 2013;59(6):1264\u201370.","journal-title":"J Hepatol"},{"issue":"2","key":"2045_CR26","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.3390\/ijms24021417","volume":"24","author":"KS Jeng","year":"2023","unstructured":"Jeng KS, Chang CF, Sheen IS, Jeng CJ, Wang CH. Cellular and molecular biology of cancer stem cells of hepatocellular carcinoma. Int J Mol Sci. 2023;24(2):1417.","journal-title":"Int J Mol Sci"},{"issue":"18","key":"2045_CR27","doi-asserted-by":"publisher","first-page":"6753","DOI":"10.3390\/ijms21186753","volume":"21","author":"A Galli","year":"2020","unstructured":"Galli A, Munnia A, Cellai F, Tarocchi M, Ceni E, van Schooten FJ, et al. Ligation-Mediated polymerase chain reaction detection of 8-Oxo-7,8-Dihydro-2\u2019-Deoxyguanosine and 5-Hydroxycytosine at the codon 176 of the p53 gene of hepatitis C-Associated hepatocellular carcinoma patients. Int J Mol Sci. 2020;21(18):6753.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2045_CR28","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1007\/s00330-020-06687-y","volume":"30","author":"A Kitao","year":"2020","unstructured":"Kitao A, Matsui O, Yoneda N, Kozaka K, Kobayashi S, Koda W, et al. Gadoxetic acid-enhanced MR imaging for hepatocellular carcinoma: molecular and genetic background. Eur Radiol. 2020;30(6):3438\u201347.","journal-title":"Eur Radiol"},{"issue":"12","key":"2045_CR29","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1038\/s41416-024-02849-7","volume":"131","author":"C Dantzer","year":"2024","unstructured":"Dantzer C, Dif L, Vach\u00e9 J, Basbous S, Billottet C, Moreau V. Specific features of \u00df-catenin-mutated hepatocellular carcinomas. Br J Cancer. 2024;131(12):1871\u201380.","journal-title":"Br J Cancer"},{"issue":"2","key":"2045_CR30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/hepr.12911","volume":"48","author":"A Kitao","year":"2018","unstructured":"Kitao A, Matsui O, Yoneda N, Kozaka K, Kobayashi S, Koda W, et al. Gadoxetic acid-enhanced magnetic resonance imaging reflects co-activation of \u03b2-catenin and hepatocyte nuclear factor 4\u03b1 in hepatocellular carcinoma. Hepatol Res. 2018;48(2):205\u201316.","journal-title":"Hepatol Res"},{"issue":"1","key":"2045_CR31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/jmri.27538","volume":"54","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Lv X, Qiu J, Zhang B, Zhang L, Fang J, et al. Deep learning with 3D convolutional neural network for noninvasive prediction of microvascular invasion in hepatocellular carcinoma. J Magn Reson Imaging. 2021;54(1):134\u201343.","journal-title":"J Magn Reson Imaging"},{"issue":"18","key":"2045_CR32","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.3390\/cancers13184635","volume":"13","author":"D Santucci","year":"2021","unstructured":"Santucci D, Faiella E, Cordelli E, Calabrese A, Landi R, de Felice C, et al. The impact of tumor edema on T2-Weighted 3T-MRI invasive breast cancer histological characterization: A pilot radiomics study. Cancers. 2021;13(18):4635.","journal-title":"Cancers"},{"issue":"10","key":"2045_CR33","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.diii.2023.04.007","volume":"104","author":"T Bouyer","year":"2023","unstructured":"Bouyer T, Roux M, Jacquemin S, Dioguardi Burgio M, Sutter O, Laurent-Crois\u00e9 V, et al. Detection of arterial phase hyperenhancement of small hepatocellular carcinoma with MRI: comparison between single arterial and multi-arterial phases and between extracellular and hepatospecific contrast agents. Diagn Interv Imaging. 2023;104(10):477\u201384.","journal-title":"Diagn Interv Imaging"},{"issue":"16","key":"2045_CR34","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.4254\/wjh.v7.i16.1987","volume":"7","author":"AP Matos","year":"2015","unstructured":"Matos AP, Velloni F, Ramalho M, AlObaidy M, Rajapaksha A, Semelka RC. Focal liver lesions: practical magnetic resonance imaging approach. World J Hepatol. 2015;7(16):1987\u20132008.","journal-title":"World J Hepatol"},{"issue":"2","key":"2045_CR35","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s00330-020-07162-4","volume":"31","author":"HJ Kang","year":"2021","unstructured":"Kang HJ, Lee JM, Jeon SK, Jang S, Park S, Joo I, et al. Intra-individual comparison of dual portal venous phases for non-invasive diagnosis of hepatocellular carcinoma at Gadoxetic acid-enhanced liver MRI. Eur Radiol. 2021;31(2):824\u201333.","journal-title":"Eur Radiol"},{"issue":"11","key":"2045_CR36","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.3390\/en10111830","volume":"10","author":"M Ali","year":"2017","unstructured":"Ali M, Son D-H, Kang S-H, Nam S-R. An accurate CT saturation classification using a deep learning approach based on unsupervised feature extraction and supervised fine-tuning strategy. Energies. 2017;10(11):1830.","journal-title":"Energies"},{"issue":"4","key":"2045_CR37","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1245\/s10434-024-16697-5","volume":"32","author":"Y Gan","year":"2025","unstructured":"Gan Y, Hu Q, Shen Q, Lin P, Qian Q, Zhuo M, et al. Comparison of intratumoral and peritumoral deep Learning, Radiomics, and fusion models for predicting KRAS gene mutations in rectal cancer based on endorectal ultrasound imaging. Ann Surg Oncol. 2025;32(4):3019\u201330.","journal-title":"Ann Surg Oncol"},{"key":"2045_CR38","doi-asserted-by":"publisher","first-page":"110899","DOI":"10.1016\/j.ejrad.2023.110899","volume":"165","author":"S Duan","year":"2023","unstructured":"Duan S, Hua Y, Cao G, Hu J, Cui W, Zhang D, et al. Differential diagnosis of benign and malignant vertebral compression fractures: comparison and correlation of radiomics and deep learning frameworks based on spinal CT and clinical characteristics. Eur J Radiol. 2023;165:110899.","journal-title":"Eur J Radiol"},{"issue":"12","key":"2045_CR39","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.21037\/tlcr-24-646","volume":"13","author":"X Wang","year":"2024","unstructured":"Wang X, Ma C, Jiang Q, Zheng X, Xie J, He C, et al. Performance of deep learning model and radiomics model for preoperative prediction of spread through air spaces in the surgically resected lung adenocarcinoma: a two-center comparative study. Translational Lung Cancer Res. 2024;13(12):3486\u201399.","journal-title":"Translational Lung Cancer Res"},{"issue":"5","key":"2045_CR40","doi-asserted-by":"publisher","first-page":"055015","DOI":"10.1088\/1361-6560\/adabad","volume":"70","author":"A Yadav","year":"2025","unstructured":"Yadav A, Welland S, Hoffman JM, Hyun JKG, Brown MS, Prosper AE, et al. A comparative analysis of image harmonization techniques in mitigating differences in CT acquisition and reconstruction. Phys Med Biol. 2025;70(5):055015.","journal-title":"Phys Med Biol"},{"issue":"12","key":"2045_CR41","doi-asserted-by":"publisher","first-page":"9038","DOI":"10.1007\/s00330-023-09953-x","volume":"33","author":"Z Xu","year":"2023","unstructured":"Xu Z, An C, Shi F, Ren H, Li Y, Chen S, et al. Automatic prediction of hepatic arterial infusion chemotherapy response in advanced hepatocellular carcinoma with deep learning radiomic nomogram. Eur Radiol. 2023;33(12):9038\u201351.","journal-title":"Eur Radiol"},{"issue":"3","key":"2045_CR42","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s41666-023-00139-0","volume":"7","author":"G Huang","year":"2023","unstructured":"Huang G, Liu H, Gong S, Ge Y. Survival prediction after transarterial chemoembolization for hepatocellular carcinoma: a deep multitask survival analysis approach. J Healthc Inf Res. 2023;7(3):332\u201358.","journal-title":"J Healthc Inf Res"},{"key":"2045_CR43","doi-asserted-by":"publisher","first-page":"111348","DOI":"10.1016\/j.ejrad.2024.111348","volume":"172","author":"X He","year":"2024","unstructured":"He X, Xu Y, Zhou C, Song R, Liu Y, Zhang H, et al. Prediction of microvascular invasion and pathological differentiation of hepatocellular carcinoma based on a deep learning model. Eur J Radiol. 2024;172:111348.","journal-title":"Eur J Radiol"},{"issue":"1","key":"2045_CR44","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/jmri.28745","volume":"59","author":"X Dong","year":"2024","unstructured":"Dong X, Yang J, Zhang B, Li Y, Wang G, Chen J, et al. Deep learning radiomics model of dynamic Contrast-Enhanced MRI for evaluating vessels encapsulating tumor clusters and prognosis in hepatocellular carcinoma. J Magn Reson Imaging. 2024;59(1):108\u201319.","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"2045_CR45","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13244-023-01380-2","volume":"14","author":"M Chen","year":"2023","unstructured":"Chen M, Kong C, Qiao E, Chen Y, Chen W, Jiang X, et al. Multi-algorithms analysis for pre-treatment prediction of response to transarterial chemoembolization in hepatocellular carcinoma on multiphase MRI. Insights into Imaging. 2023;14(1):38.","journal-title":"Insights into Imaging"},{"issue":"1","key":"2045_CR46","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s00330-022-09026-5","volume":"33","author":"T Cao","year":"2023","unstructured":"Cao T, Jiang R, Zheng L, Zhang R, Chen X, Wang Z, et al. T1 and ADC histogram parameters May be an in vivo biomarker for predicting the grade, subtype, and proliferative activity of meningioma. Eur Radiol. 2023;33(1):258\u201369.","journal-title":"Eur Radiol"},{"key":"2045_CR47","doi-asserted-by":"publisher","first-page":"805545","DOI":"10.3389\/fonc.2021.805545","volume":"11","author":"X Jiang","year":"2021","unstructured":"Jiang X, Jia H, Zhang Z, Wei C, Wang C, Dong J. The feasibility of combining ADC value with texture analysis of T2WI, DWI and CE-T1WI to preoperatively predict the expression levels of Ki-67 and p53 of endometrial carcinoma. Front Oncol. 2021;11:805545.","journal-title":"Front Oncol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-02045-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-02045-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-02045-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T02:02:40Z","timestamp":1766455360000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-025-02045-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2045"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-02045-w","relation":{},"ISSN":["1471-2342"],"issn-type":[{"type":"electronic","value":"1471-2342"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Ethics Committee of First Clinical Hospital of Lanzhou University, which waived the requirement for informed consent. All procedures were carried out in accordance with the relevant guidelines and regulations, and the study was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"506"}}